Hu PS

No ORCID on file · 4 papers in corpus · active 2024-2026
2026
Unravelling the Contribution of Matrix Metalloproteinase-3 Genotype-Phenotype to Pterygium Risk.
Cancer genomics & proteomics ·doi:10.21873/cgp.20573

Background/aimPterygium is a fibrovascular ocular disease characterized by extracellular matrix (ECM) remodeling. Matrix metalloproteinase-3 (MMP-3), a key ECM-modulating enzyme, has been implicated to involved in pterygium progression, but…

2025
Exploring the Genetic Role of Matrix Metalloproteinase-13 Variants in Pterygium Risk.
In vivo (Athens, Greece) ·doi:10.21873/invivo.14116

Background/aimPterygium is a common ocular surface disorder characterized by abnormal fibrovascular growth and extracellular matrix remodeling, yet its precise molecular etiology remains unclear. Matrix metalloproteinases (MMPs) have been i…

2024
Contribution of Matrix Metalloproteinase-2 Genotypes to Taiwan Pterygium Risk.
In vivo (Athens, Greece) ·doi:10.21873/invivo.13472

Background/aimIn the literature, the studies about the role of matrix metalloproteinase-2 (MMP-2) in pterygium diagnosis are mainly based on its protein expression. The role of MMP-2 variants has never been examined. The aim of this study w…

2024
Contribution of Radiation Sensitive Protein 51 Genotypes to Pterygium Risk in a Taiwanese Population.
In vivo (Athens, Greece) ·doi:10.21873/invivo.13683

Background/aimIn current literature, there is a notable lack of studies investigating the role of radiation-sensitive protein 51 (RAD-51) in pterygium diagnosis. Nevertheless, reports indicate elevated expression levels of RAD-51 among recu…